Skip to Main Content

Paper Details

An Early Neoplasia Index (ENI10), Based on Molecular Identity of CD10 Cells and Associated Stemness Biomarkers, is a Predictor of Patient Outcome in Many Cancers.
Cancer Res Commun
0
2023
Author NameAffiliation
Laurie TononSynergie Lyon Cancer Foundation
Helen He ZhuRenji-Med-X Stem Cell Research Center, Shanghai Cancer Institute and Department of Urology, Ren Ji Hospital, Shanghai Jiao Tong University
Franck TirodeCNRS UMR6
Franck TirodeInserm U2
Franck Tirode
Franck TirodeUniversite Claude Bernard Lyon 1
Franck Tirode
  • 1 - 7

Datasets